Copyright © Inderes 2011 - present. All rights reserved.

Nanoform Finland

1.108

 

EUR

 

-1.77 %

NANOFH

First North Finland

Medical Equipment & Services

Health Care

3,448 following
-1.77%
-4.65%
-28.24%
-35.58%
-45.95%
-30.09%
-34.05%
-85.23%
-
-78.06%
nanoform.com/en/section/investors

Nanoform Finland is a medical technology company. The company specializes in the research and development of technical products used to create nanoparticles in pharmaceuticals. The technology is used as a complement in the production process and is used for the treatment of diseases such as ALS and Alzheimer's. The customers consist of companies in the global pharmaceutical industry. Nanoform Finland mainly operates in the Nordic market and is headquartered in Helsinki.

Revenue
2.57M
EBIT %
-874.71 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Finland
NANOFH
Daily low / high price
1.108 / 1.24 EUR
Market cap
94.77M EUR
Turnover
188.96K EUR
Volume
164K

Latest videos

Nanoform, Audiocast with teleconference, Q3'24
2024-11-18
Nanoform, Audiocast with teleconference, Q2'24
2024-08-29
Nanoform, Audiocast with teleconference, Q1'24
2024-05-30

Financial calendar

Interim report
2024-11-18
Annual report
2025-02-27

Major Owners
Source: Millistream Market Data AB

OwnerCapitalVotes
Handelsbanken Funds7.1 %7.1 %
Edward Hæggström6.3 %6.3 %
Helsinki University Funds5.1 %5.1 %
Mandatum Life Insurance Company5.0 %5.0 %
The Fourth Swedish National Pension Fund4.7 %4.7 %
Keel Capital4.5 %4.5 %
Varma Mutual Pension Insurance Company4.5 %4.5 %
Arbejdsmarkedets Tillaegspension (ATP)4.3 %4.3 %
Danske Invest3.9 %3.9 %
Kai Falck3.2 %3.2 %
Login in to make your own estimates and see other investors estimates.
ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account